Pseudotumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-07-02
Clinical Trial Update: Rituximab in IgG4-RD: A Phase 1-2 Trial [Phase 1, Phase 2]
Phase 1/2 trial evaluating rituximab for IgG4-related disease has completed enrollment and posted results. The study examined retroperitonea…